Walgreens Boots Alliance Inc

Walgreens Boots Alliance Inc

WBA

Get informed when a big investor buys or sells

+ Follow
Market Cap$10.37B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Walgreens Boots Alliance IncWalgreens Boots Alliance Inc-3.42.09%-88%0.14.1
$20.51

Current Fair Value

71.2% upside

Undervalued by 71.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$10.37 Billion
Enterprise Value$38.87 Billion
Dividend Yield$0.25 (2.09%)
Earnings per Share$-10.01
Beta0.77
Outstanding Shares864,900,000

Return

Return on Equity-87.68%ROE
Return on Assets-9.07%
Return on Invested Capital-9.32%

Valuation & Multiples

P/E Ratio-3.42P/E Ratio
PEG2.27PEG
Price to Sales0.07Price to Sales
Price to Book Ratio1.5Price to Book Ratio
Enterprise Value to Revenue0.25
Enterprise Value to EBIT-9.6
Enterprise Value to Net Income-7
Total Debt to Enterprise0.75
Debt to Equity4.07Debt to Equity

Revenue Sources

No data

Insider Trades

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio1.0851 23.63%
Total Calls21,805,800 16.46%
Total Puts23,662,223 6.80%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %62.99% 1.46%
Total Invested$6.25B 3.79%
Investors Holding874 43.00%

ESG Score

No data

About Walgreens Boots Alliance Inc

CEO: Stefano Pessina

Relevant Senate Committees

Finance

This committee directly impacts WBA through its control over taxation (corporate tax policy) and entitlement spending, particularly Medicare pricing, which is a critical factor for pharmacy reimbursement rates and profitability.

Appropriations

This committee directly allocates discretionary federal spending, which includes funding for government healthcare programs (e.g., Medicare, Medicaid, VA) whose reimbursement rates significantly impact WBA's pharmacy revenue.

Health, Education, Labor, and Pensions

This committee's regulation of the FDA (drug approval and safety) directly impacts products WBA sells, and its influence on labor laws (minimum wage, unionization) directly affects WBA's significant workforce and operating costs.

Special Committee on Aging

This committee directly investigates issues affecting older Americans, including drug pricing and long-term care quality, which are highly relevant to WBA's core pharmacy business and can generate significant headline risk and legislative pressure.

Commerce, Science, and Transportation

This committee's jurisdiction over interstate commerce and the FTC directly impacts WBA's retail and consumer protection practices, advertising, and data privacy regulations as a large national retailer.